Biological aging across the metabolic dysfunction-associated steatotic liver disease spectrum: A systematic review.

Chukwuemeka E Ogbu, Stella C Ogbu, Chidera P Ogbu, Chinazor Umerah

Internal Medicine Residency Program, Cape Fear Valley Health, Fayetteville, NC 28304, USA.Internal Medicine Residency Program, Cape Fear Valley Health, Fayetteville, NC 28304, USA. · pubmed

Paper

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health burden. Geroscience posits that accelerated biological aging is a key driver of chronic disease. We systematically reviewed the evidence to define the role of biological aging (BA) across the MASLD disease spectrum.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims to define the role of biological aging across the MASLD disease spectrum. The research addresses biological aging as a key driver of chronic disease, which aligns with the exploration of root causes of aging and their implications for longevity.

Author of this paper? Send a correction.